WILMINGTON, MA — Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the promotion of Joe Laskey, formerly Managing Director of Asian Sales and Business Development, to Area Vice President and General Manager of Asian Sales and Business Development, which includes China, Russia, Japan and the ‘Stans’ (Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan and Kyrgyzstan).

Glenn D. Bolduc, Implant Sciences’ President and CEO, stated, “Joe’s promotion to Area VP is in recognition of the significant market traction he has helped Implant Sciences achieve in Asia. Thanks in large part to his efforts, we expect to see continued near and long term growth in the region.”

“Joe Laskey has developed strong relationships with channel partners and security organizations, building Implant Sciences into a highly respected brand in his territory,” added Bruce Bower, Senior Vice President, Implant Sciences. “His keen understanding of the challenges faced by those opposing terrorism have made Joe a valued resource to his customers. We are pleased to recognize his many achievements and look forward to his continued success in growing Implant Sciences’ presence in this important market.”

China represents Implant Sciences’ largest installed customer base with more than 800 Quantum Sniffer™ QS-H150 units shipped. The Company’s new bench-top explosives trace detector, the Quantum Sniffer™ QS-B220, is now being tested in Beijing and being presented to potential customers in China.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com : .